No clinical trial has tested this combination, but the pharmacological logic supports the approach for researchers operating at the cutting edge
The 1.4% gallbladder event rate in Phase 2 can be mitigated by maintaining 30 to 50 grams of healthy fats daily
There is a drop in satiety hormones (such as leptin, amylin, CCK and PYY), whereas the orexigenic ghrelin and NPY increase
Additionally, patients using both treatments may attribute weight loss or adverse effects to the wrong agent, complicating clinical assessment
You may safely travel with Oral Compounded GLP-1 Drops, so long as the above conditions are met
Some research has shown that GLP-1s may cause gastroparesis, or stomach paralysis, in some people